Strategic Partnership Between Careviso and XiFin
In a groundbreaking move to enhance the efficiency of diagnostic laboratories, careviso has formed a strategic alliance with XiFin. This partnership is aimed at modernizing prior authorization processes and revenue cycle management for healthcare providers. By leveraging careviso's robust prior authorization services alongside XiFin's industry-leading revenue cycle management solutions, the collaboration seeks to streamline operations and improve patient access to essential healthcare services.
Streamlining Operations for Diagnostic Laboratories
The integration of careviso and XiFin’s technologies is set to considerably enhance the operational efficiencies of their clients. As the healthcare landscape continues to evolve, laboratories face increasing challenges in navigating complex workflows, claim submissions, and patient access. By automating processes and combining their strengths, careviso and XiFin are poised to revolutionize the way diagnostic services are provided.
Emphasizing Innovation and Efficiency
Since its inception, careviso has been at the forefront of healthcare innovation, having completed over 2 million prior authorizations since 2018. This success is attributed to their customer-first approach and robust analytics capabilities that connect healthcare providers to over 4,000 payors. This extensive network not only facilitates smoother prior authorization processes but also helps healthcare providers maintain compliance with regulatory standards.
Xifin’s Expertise in Revenue Cycle Management
On the other hand, XiFin brings significant expertise in revenue cycle management to the table. Known for its AI-driven solutions, XiFin helps labs, pharmacies, and health systems optimize their operations and improve financial performance. By identifying areas of improvement, XiFin minimizes claim denials and accelerates the revenue cycle, thereby allowing healthcare organizations to focus on delivering high-quality patient care.
Improving Patient Access and Outcomes
This partnership is not merely about enhancing the operations of diagnostic laboratories; it also prioritizes patient access to necessary health services. By ensuring that the prior authorization and claims processes are both timely and accurate, careviso and XiFin enable healthcare providers to direct their efforts toward improving patient outcomes. This alignment of operational efficiency with patient care creates a win-win situation for all stakeholders involved.
Real-world Impact
The alliance has already begun to yield tangible results. A major publicly traded genetic testing company is currently benefiting from the combined expertise of careviso and XiFin. This collaboration enables the company to better support patients with rare disorders by facilitating quicker access to the critical diagnostics they need. Such an initiative exemplifies the practical applications of the partnership in real-world scenarios.
Quotes from Leadership
Andrew Mignatti, the CEO of careviso, expressed enthusiasm about the partnership, stating, "Partnering in this alliance with XiFin allows careviso to expand our mission of simplifying access to healthcare. By combining our strengths in benefits investigation and prior authorization with XiFin's leadership in revenue cycle management, we are setting a new standard for our clients."
Similarly, Lâle White, executive chair and CEO of XiFin, remarked, "Prior authorization continues to be a critical challenge across the entire healthcare system. By working with careviso, we aim to help customers lower costs, accelerate approvals, and reduce denials, ultimately improving patient access to necessary diagnostics and care." This partnership is about more than numbers; it's about the positive influence on patient lives.
Unlocking Integrated Services
Careviso and XiFin invite diagnostic laboratories to seize the opportunities presented by their innovative alliance. With a focus on integrating prior authorization services with revenue cycle management, this partnership empowers laboratories to enhance their financial performance. The synergy created by this collaboration alleviates administrative burdens while simultaneously improving the overall patient experience.
About Careviso
Founded in 2018, careviso aims to transform the healthcare experience by streamlining prior authorization processes and enhancing financial transparency. With a commitment to innovation and efficiency, careviso has facilitated over 2 million prior authorizations and numerous financial transparency transactions, reinforcing its role as a trusted partner in healthcare.
About XiFin
XiFin is dedicated to empowering healthcare organizations in navigating the complexities of the evolving healthcare landscape. Offering a comprehensive suite of solutions, XiFin enhances operational efficiency and workflow automation, helping organizations achieve financial strength. Their commitment to delivering innovative healthcare solutions is reflected in their mission of providing THE POWER TO DO GOOD™ for patients.
Frequently Asked Questions
What is the focus of the alliance between careviso and XiFin?
The alliance focuses on modernizing prior authorization and revenue cycle management to enhance the efficiency of diagnostic laboratories.
How will this partnership benefit diagnostic laboratories?
By integrating their solutions, the partnership aims to streamline workflows and improve claim submissions, ultimately optimizing patient access to diagnostic services.
What expertise does XiFin bring to the partnership?
XiFin offers AI-driven revenue cycle management solutions that help healthcare organizations maximize reimbursements and minimize claim denials.
How has careviso established itself in the healthcare industry?
Careviso has successfully completed over 2 million prior authorizations and has established strong connections with over 4,000 payors, enhancing compliance and efficiency.
What do the leaders of both companies say about the partnership?
Both Andrew Mignatti and Lâle White emphasize the importance of this partnership in addressing prior authorization challenges and improving patient access to necessary diagnostics.
